Bio Essence Corporation (BIOE)

OTCMKTS · Delayed Price · Currency is USD

0.3000

+0.0260 (9.49%)

May 22, 2026, 4:00 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Manufacture / OEM and Sale of Health Supplement Products	1.90M	323.94K		621.59K	887.98K	958.70K
Manufacture / OEM and Sale of Health Supplement Products Growth	485.78%	-		-30.00%	-7.38%	16.02%
Total	1.90M	323.94K		621.59K	887.98K	958.70K
Total Growth	485.78%	-		-30.00%	-7.38%	16.02%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
United States	1.90M	323.94K		621.59K	887.98K	958.70K
United States Growth	485.78%	-		-30.00%	-7.38%	16.02%
Total	1.90M	323.94K		621.59K	887.98K	958.70K
Total Growth	485.78%	-		-30.00%	-7.38%	16.02%

Source: S&P Global Market Intelligence.